Amplifon S.p.A. (AMFPF) Research

Amplifon S.p.A. is a company dedicated to empowering individuals to rediscover the joy and nuances of sound through its comprehensive offerings of hearing care products and services. Their product line features various hearing aids, including the ampli-easy, ampli-mini, ampli-connect, and ampli-energy series. Additionally, they provide specialized fitting services for customized devices, ensuring optimal user experience. As of March 18, 2022, Amplifon had established a significant global presence, operating approximately 9,200 retail points of sale across 25 countries and five continents. The company's extensive reach is further supported by a network of 1,350 franchisees. Its operations span diverse geographical areas, encompassing Europe, the Middle East, Africa, the United States, Asia, and Oceania. Amplifon S.p.A., which was established in 1950, is headquartered in Milan, Italy.

Market snapshot

Symbol
AMFPF
Price
$12.01
Day change
0.00%
Market cap
$2.2B
P/E ratio
32.84x
52-week range
9.46-23.85
Sector
Healthcare
Industry
Medical - Devices
Next earnings
in 1 month

Recent news

  • EssilorLuxottica considered investing in Amplifon in the past, CEO says

    Franco-Italian eyewear giant EssilorLuxottica looked at investing ​in Italian hearing aid ‌maker Amplifon in the past, CEO Francesco Milleri said on ​Tuesday.

Peer companies

  • Ambu A/S (AMBBY)
  • Bumrungrad Hospital Public Company Limited (BUGDF)
  • Bumrungrad Hospital Public Company Limited (BUHPF)
  • Carl Zeiss Meditec AG (CZMWF)
  • Carl Zeiss Meditec AG (CZMWY)
  • MediPal Holdings Corporation (MAHLY)
  • MediPal Holdings Corporation (MEPDF)
  • Nihon Kohden Corporation (NHNKY)

Open Amplifon S.p.A. (AMFPF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.